390 related articles for article (PubMed ID: 33735106)
1. Lymphocyte may be a reference index of the outcome of cancer patients with COVID-19.
Zhang W; Gao Y; Hu G; Chu Q; Yuan X
Aging (Albany NY); 2021 Mar; 13(6):7733-7744. PubMed ID: 33735106
[TBL] [Abstract][Full Text] [Related]
2. Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19.
Liu Y; Tan W; Chen H; Zhu Y; Wan L; Jiang K; Guo Y; Tang K; Xie C; Yi H; Kuang Y; Luo Y
BMC Infect Dis; 2021 Jan; 21(1):79. PubMed ID: 33461503
[TBL] [Abstract][Full Text] [Related]
3. Clinical Characteristics and Immune Responses of 137 Deceased Patients With COVID-19: A Retrospective Study.
Cui N; Yan R; Qin C; Zhao J
Front Cell Infect Microbiol; 2020; 10():595333. PubMed ID: 33365277
[TBL] [Abstract][Full Text] [Related]
4. Cytokines and their relationship with the severity and prognosis of coronavirus disease 2019 (COVID-19): a retrospective cohort study.
Liu QQ; Cheng A; Wang Y; Li H; Hu L; Zhao X; Wang T; He F
BMJ Open; 2020 Nov; 10(11):e041471. PubMed ID: 33257492
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID-19.
Ni M; Tian FB; Xiang DD; Yu B
J Med Virol; 2020 Nov; 92(11):2600-2606. PubMed ID: 32470153
[TBL] [Abstract][Full Text] [Related]
6. Peripheral Inflammatory Cytokines and Lymphocyte Subset Features of Deceased COVID-19 Patients.
Jiang N; Li Z; Yang B; Jin M; Sun Y; He Y; Liu Y; Wang Y; Si D; Ma P; Zhang J; Liu T; Yu Q
Biomed Res Int; 2021; 2021():9101082. PubMed ID: 33542929
[TBL] [Abstract][Full Text] [Related]
7. Risk Factors for Mortality of COVID-19 Patient Based on Clinical Course: A Single Center Retrospective Case-Control Study.
Zhang J; Wang Z; Wang X; Hu Z; Yang C; Lei P
Front Immunol; 2021; 12():581469. PubMed ID: 33664741
[No Abstract] [Full Text] [Related]
8. Dynamics of cytokines and lymphocyte subsets associated with the poor prognosis of severe COVID-19.
Li Q; Xu W; Li WX; Huang CL; Chen L
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12536-12544. PubMed ID: 33336774
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics and peripheral immunocyte subsets alteration of 85 COVID-19 deaths.
Xiong L; Zang X; Feng G; Zhao F; Wang S; Zeng W; Yu K; Zhai Y
Aging (Albany NY); 2021 Mar; 13(5):6289-6297. PubMed ID: 33711813
[TBL] [Abstract][Full Text] [Related]
10. Immunological alternation in COVID-19 patients with cancer and its implications on mortality.
Cai G; Gao Y; Zeng S; Yu Y; Liu X; Liu D; Wang Y; Yu R; Desai A; Li C; Gao Q
Oncoimmunology; 2021 Jan; 10(1):1854424. PubMed ID: 33489469
[TBL] [Abstract][Full Text] [Related]
11. Leucocyte Subsets Effectively Predict the Clinical Outcome of Patients With COVID-19 Pneumonia: A Retrospective Case-Control Study.
Gan J; Li J; Li S; Yang C
Front Public Health; 2020; 8():299. PubMed ID: 32626680
[No Abstract] [Full Text] [Related]
12. Prediction Model Based on the Combination of Cytokines and Lymphocyte Subsets for Prognosis of SARS-CoV-2 Infection.
Luo Y; Mao L; Yuan X; Xue Y; Lin Q; Tang G; Song H; Wang F; Sun Z
J Clin Immunol; 2020 Oct; 40(7):960-969. PubMed ID: 32661797
[TBL] [Abstract][Full Text] [Related]
13. Association and Interaction Between Serum Interleukin-6 Levels and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients With Severe Coronavirus Disease 2019.
Gao F; Zheng KI; Yan HD; Sun QF; Pan KH; Wang TY; Chen YP; Targher G; Byrne CD; George J; Zheng MH
Front Endocrinol (Lausanne); 2021; 12():604100. PubMed ID: 33763027
[TBL] [Abstract][Full Text] [Related]
14. Elevated Exhaustion Levels of NK and CD8
Li M; Guo W; Dong Y; Wang X; Dai D; Liu X; Wu Y; Li M; Zhang W; Zhou H; Zhang Z; Lin L; Kang Z; Yu T; Tian C; Qin R; Gui Y; Jiang F; Fan H; Heissmeyer V; Sarapultsev A; Wang L; Luo S; Hu D
Front Immunol; 2020; 11():580237. PubMed ID: 33154753
[TBL] [Abstract][Full Text] [Related]
15. High Levels of Circulating IL-8 and Soluble IL-2R Are Associated With Prolonged Illness in Patients With Severe COVID-19.
Ma A; Zhang L; Ye X; Chen J; Yu J; Zhuang L; Weng C; Petersen F; Wang Z; Yu X
Front Immunol; 2021; 12():626235. PubMed ID: 33584733
[TBL] [Abstract][Full Text] [Related]
16. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
[TBL] [Abstract][Full Text] [Related]
17. Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak.
Wang Z; Wang Z
BMC Infect Dis; 2021 Jan; 21(1):113. PubMed ID: 33494706
[TBL] [Abstract][Full Text] [Related]
18. T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression.
Gil-Etayo FJ; Suàrez-Fernández P; Cabrera-Marante O; Arroyo D; Garcinuño S; Naranjo L; Pleguezuelo DE; Allende LM; Mancebo E; Lalueza A; Díaz-Simón R; Paz-Artal E; Serrano A
Front Cell Infect Microbiol; 2021; 11():624483. PubMed ID: 33718270
[TBL] [Abstract][Full Text] [Related]
19. Clinical and immunological features of severe and moderate coronavirus disease 2019.
Chen G; Wu D; Guo W; Cao Y; Huang D; Wang H; Wang T; Zhang X; Chen H; Yu H; Zhang X; Zhang M; Wu S; Song J; Chen T; Han M; Li S; Luo X; Zhao J; Ning Q
J Clin Invest; 2020 May; 130(5):2620-2629. PubMed ID: 32217835
[TBL] [Abstract][Full Text] [Related]
20. Specific dynamic variations in the peripheral blood lymphocyte subsets in COVID-19 and severe influenza A patients: a retrospective observational study.
Qian F; Gao G; Song Y; Xu Y; Wang A; Wang S; Hao Y; Chen M; Ma X; Zhao T; Guo X; Chen Z; Zhang F
BMC Infect Dis; 2020 Dec; 20(1):910. PubMed ID: 33261583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
